PubMed Cox, H.D., Smeal, S.J., Hughes, C.M., Cox, J.E., & Eichner, D
De hecho, los anlisis de mediacin realizados sugirieron que solo aproximadamente el 25% del beneficio sobre los resultados renales puede estar mediado por un mejor control glucmico y un 9-22% por los cambios sobre la presin arterial92,106, lo que sugiere el papel de mecanismos directos: reduccin de la hiperfiltracin, del estrs oxidativo y de la inflamacin, efectos antifibrticos, mejora de la disfuncin endotelial y/o posible reduccin de niveles de angiotensina ii52,54,107109
Per results of a phase 1 study, a long-acting GIPRA used in combination with a rapidly escalated, selective GLP-1RA demonstrated mild weight loss with reduced gastrointestinal adverse events in participants with or without T2D [17]
Pharmacy Benefit Managers (PBMs) are playing a crucial role by negotiating hefty rebates with manufacturers in exchange for formulary placement
Frustrated by the lack of quality products on the market, Hany set out to create solutions that truly deliver results
